Fosun International Ltd Invests $940,000 in Clorox Co (CLX)
Fosun International Ltd purchased a new stake in shares of Clorox Co (NYSE:CLX) in the third quarter, HoldingsChannel.com reports. The institutional investor purchased 6,300 shares of the company’s stock, valued at approximately $940,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in CLX. Parnassus Investments CA increased its stake in Clorox by 1.6% in the 2nd quarter. Parnassus Investments CA now owns 4,711,970 shares of the company’s stock worth $637,294,000 after purchasing an additional 76,149 shares during the period. Macquarie Group Ltd. increased its stake in Clorox by 437,400.0% in the 2nd quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock worth $236,688,000 after purchasing an additional 1,749,600 shares during the period. Bank of New York Mellon Corp increased its stake in Clorox by 15.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,664,803 shares of the company’s stock worth $250,403,000 after purchasing an additional 218,364 shares during the period. Schroder Investment Management Group increased its stake in Clorox by 57.0% in the 2nd quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock worth $201,641,000 after purchasing an additional 547,070 shares during the period. Finally, Morgan Stanley increased its stake in Clorox by 44.2% in the 2nd quarter. Morgan Stanley now owns 1,101,380 shares of the company’s stock worth $148,962,000 after purchasing an additional 337,621 shares during the period. 76.33% of the stock is currently owned by institutional investors.
CLX opened at $160.41 on Wednesday. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07. Clorox Co has a 52-week low of $113.57 and a 52-week high of $163.44. The company has a market cap of $20.73 billion, a PE ratio of 25.62, a price-to-earnings-growth ratio of 3.99 and a beta of 0.28.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 8th. Stockholders of record on Wednesday, January 23rd will be paid a dividend of $0.96 per share. The ex-dividend date is Tuesday, January 22nd. This represents a $3.84 annualized dividend and a dividend yield of 2.39%. Clorox’s dividend payout ratio (DPR) is presently 61.34%.
In related news, SVP Michael R. Costello sold 6,882 shares of Clorox stock in a transaction that occurred on Thursday, November 15th. The stock was sold at an average price of $160.08, for a total transaction of $1,101,670.56. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Dawn C. Willoughby sold 54,205 shares of Clorox stock in a transaction that occurred on Tuesday, November 6th. The shares were sold at an average price of $157.39, for a total value of $8,531,324.95. Following the sale, the chief operating officer now owns 37,044 shares in the company, valued at $5,830,355.16. The disclosure for this sale can be found here. Insiders have sold 93,970 shares of company stock worth $14,567,178 over the last three months. Insiders own 1.40% of the company’s stock.
CLX has been the topic of a number of analyst reports. Zacks Investment Research cut Clorox from a “buy” rating to a “hold” rating in a research note on Friday, October 5th. BMO Capital Markets lifted their price target on Clorox from $153.00 to $165.00 and gave the stock a “buy” rating in a research note on Friday, November 2nd. ValuEngine raised Clorox from a “hold” rating to a “buy” rating in a research note on Saturday, September 22nd. Citigroup boosted their target price on Clorox from $149.00 to $153.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. Finally, Argus raised Clorox from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research note on Tuesday, September 25th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $142.79.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: What is a Stop Order?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.